OxyContin OxyContin
Stories About

OxyContin

Activists hold a banner reading "Take down the Sackler name" in front of the Pyramid of the Louvre museum in Paris on July 1, 2019. Stephane De Sakutin/AFP via Getty Images hide caption

toggle caption
Stephane De Sakutin/AFP via Getty Images

'All the Beauty and the Bloodshed' chronicles Nan Goldin's career of art and activism

  • Download
  • <iframe src="https://www.npr.org/player/embed/1155094111/1155764503" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Cars pass Purdue Pharma headquarters in Stamford, Conn. A federal mediator said in a filing Friday that Purdue's owners are willing to increase their offer for a settlement in lawsuits over the toll of opioids. Frank Franklin II/AP file photo hide caption

toggle caption
Frank Franklin II/AP file photo

Purdue Pharma filed for bankruptcy with a more than $10 billion plan to settle claims that it fueled the U.S. opioid epidemic by illegally pushing sales of its addictive OxyContin painkiller. The company's headquarters in Stamford, Conn., is shown here in 2019. Victor J. Blue/Bloomberg/Getty Images hide caption

toggle caption
Victor J. Blue/Bloomberg/Getty Images

Signage for Purdue Pharma headquarters stands in downtown Stamford, April 2, 2019 in Stamford, Connecticut. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, are facing hundreds of lawsuits across the country for the company's alleged role in the opioid epidemic that has killed more than 200,000 Americans over the past 20 years. Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

As Purdue Pharma Bankruptcy Nears Approval, Family Members Write About The Human Toll

  • Download
  • <iframe src="https://www.npr.org/player/embed/1025171160/1026004366" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A 2013 file photo shows OxyContin pills at a pharmacy in Montpelier, Vt. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

Justice Department Blasts Purdue Pharma's Bankruptcy Plan

  • Download
  • <iframe src="https://www.npr.org/player/embed/1018028179/1018523914" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Purdue Pharma faced an avalanche of lawsuits for alleged harm caused by its prescription opioid medicine OxyContin. A controversial bankruptcy deal expected to be finalized next month would block lawsuits against members of the Sackler family who own the firm. Darren McCollester/Getty Images hide caption

toggle caption
Darren McCollester/Getty Images

A federal judge extended a block on lawsuits against members of the Sackler family, owners of Purdue Pharma, until April 21. The drug-maker filed for bankruptcy in 2019, facing an avalanche of claims linked to the marketing and sale of its highly addictive painkiller OxyContin. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

OxyContin pills arranged at a pharmacy in Montpelier, Vt. Purdue Pharma makes the highly addictive drug. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

Purdue Pharma Offers Restructuring Plan, Sackler Family Would Give Up Ownership

  • Download
  • <iframe src="https://www.npr.org/player/embed/977378745/977712287" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Newly public documents detail the role of members of the Sackler family, owners of OxyContin maker Purdue Pharma, during years when the privately owned drug company launched criminal schemes designed to "turbocharge" sales of Oxycontin and other highly addictive opioid medications. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

Critics Want Sacklers To Face Criminal Charges For Role In Opioid Crisis

  • Download
  • <iframe src="https://www.npr.org/player/embed/938801514/938901348" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Purdue Pharma headquarters in Stamford, Conn., in 2019. Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, have faced hundreds of lawsuits over the company's alleged role in the opioid epidemic that has killed more than 200,000 Americans. Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over OxyContin Sales

  • Download
  • <iframe src="https://www.npr.org/player/embed/926126877/926352388" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Purdue Pharma headquarters in Stamford, Conn, shown last week. The company, which makes OxyContin and other drugs, filed court papers in New York on Sunday seeking Chapter 11 bankruptcy protection. Frank Franklin II/AP hide caption

toggle caption
Frank Franklin II/AP

Members of P.A.I.N. (Prescription Addiction Intervention Now) and Truth Pharm staged a protest on Thursday outside Purdue Pharma headquarters in Stamford, Conn., over its recent controversial opioid settlement. Erik McGregor/LightRocket via Getty Images hide caption

toggle caption
Erik McGregor/LightRocket via Getty Images

Oklahoma Attorney General Mike Hunter begins closing statements during the opioid trial at the Cleveland County Courthouse in Norman, Okla., on Monday, July 15. It's the first public trial to emerge from roughly 2,000 U.S. lawsuits aimed at holding drugmakers accountable for the nation's opioid epidemic. Chris Landsberger/The Oklahoman hide caption

toggle caption
Chris Landsberger/The Oklahoman

Pain Meds As Public Nuisance? Oklahoma Tests A Legal Strategy For Opioid Addiction

  • Download
  • <iframe src="https://www.npr.org/player/embed/741960008/742436405" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

"We fully respect and support the Sackler family's decision," says a spokesperson for the National Portrait Gallery in central London, after a gift was withdrawn. Members of the Sackler family are accused of pursuing profits on OxyContin amid an opioid crisis. Daniel Leal-Olivas/AFP/Getty Images hide caption

toggle caption
Daniel Leal-Olivas/AFP/Getty Images

Families that lost loved ones to the opioid crisis protested outside Suffolk Superior Court in Boston as lawyers for Purdue Pharma entered the courthouse for a status update in the Massachusetts attorney general's suit against the company on Jan. 25. Suzanne Kreiter/Boston Globe via Getty Images hide caption

toggle caption
Suzanne Kreiter/Boston Globe via Getty Images

A filing by Massachusetts Attorney General Maura Healey detailed the Sackler family's role in Purdue Pharma's marketing of OxyContin. Toby Talbot/AP hide caption

toggle caption
Toby Talbot/AP

Despite abuse deterrent formulation, Purdue Pharma's OxyContin continues to be used by some people with opioid addiction to get high. Bloomberg/Bloomberg via Getty Images hide caption

toggle caption
Bloomberg/Bloomberg via Getty Images

Insurer To Purdue Pharma: We Won't Pay For OxyContin Anymore

  • Download
  • <iframe src="https://www.npr.org/player/embed/646790014/647180518" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dispatches From A 'Dopesick' America

  • Download
  • <iframe src="https://www.npr.org/player/embed/640530842/640627773" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript